Compared to Estimates, Adient (ADNT) Q1 Earnings: A Look at Key Metrics

Core Insights - Adient (ADNT) reported revenue of $3.64 billion for the quarter ended December 2025, marking a year-over-year increase of 4.3% and exceeding the Zacks Consensus Estimate of $3.48 billion by 4.68% [1] - The company achieved an EPS of $0.35, up from $0.27 a year ago, resulting in an EPS surprise of 74.13% compared to the consensus estimate of $0.20 [1] Financial Performance - Net Sales in the Americas reached $1.64 billion, surpassing the three-analyst average estimate of $1.54 billion, with a year-over-year change of +1.9% [4] - Net Sales in Asia amounted to $819 million, exceeding the average estimate of $796.85 million, reflecting a +6.1% change year-over-year [4] - Net Sales in EMEA totaled $1.21 billion, above the average estimate of $1.14 billion, indicating a +6.7% change compared to the previous year [4] - Net Sales for Eliminations were reported at $-22 million, slightly better than the average estimate of $-23.02 million, showing a year-over-year change of +29.4% [4] Stock Performance - Adient's shares have returned +7.8% over the past month, outperforming the Zacks S&P 500 composite's +0.9% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]